INTERNATIONAL PATENT: EVOLVEIMMUNE THERAPEUTICS, INC. FILES APPLICATION FOR "BISPECIFIC ANTIBODY FUSION MOLECULES TARGETING CD20 AND CD3 AND METHODS OF USE THEREOF"

GENEVA, April 15 -- EVOLVEIMMUNE THERAPEUTICS, INC. (23 Business Park DriveBranford, CT 06405) filed a patent application (PCT/US2025/049259) for "BISPECIFIC ANTIBODY FUSION MOLECULES TARGETING CD20 AND CD3 AND METHODS OF USE THEREOF" on Oct 02, 2025. With publication no. WO/2026/076258, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SARKAR, Mohosin (19 Timber LaneWoodbridge, CT 06525), AN, Xingyue (380 Mather St.Apt. 2405Hamden, CT 06514), PREYER, Martin (43 Weston AveSomerville, MA 02144)

Abstract: The present disclos...